Techpool Biopharma
Guangzhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese biopharma developing biologic therapies for rare diseases and metabolic disorders.
Rare DiseaseMetabolic
Technology Platform
A protein engineering and manufacturing platform focused on producing bioactive, high-purity recombinant enzymes and therapeutic proteins.
Opportunities
China's recent policy push to accelerate rare disease drug approval and improve diagnosis creates a favorable market environment.
Risk Factors
Small patient populations per indication lead to high drug prices, challenging reimbursement negotiations and market sustainability.
Competitive Landscape
Operates in a high-barrier niche competing against global rare disease giants, but with fewer local competitors.